Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Biogen's Amevive shows good results as therapy for psoriasis

Aug. 2, 2001

Infliximab effective against plaque-type psoriasis

Aug. 1, 2001

MedImmune begins additional study of siplizumab in psoriasis patients

July 27, 2001

Dusa cleared to begin three phase I/II trials with Levulan for new indications

July 26, 2001

Novel inhibitor of cPLA2 with topical and oral antiinflammatory activity

July 24, 2001

First launch for diclofenac gel formulation for actinic keratoses

July 20, 2001

Antiproliferative vitamin D analogues from Galderma particularly useful in dermatology

July 19, 2001

Therapy of psoriasis with anti-TNF-alpha antibodies

July 19, 2001

Ortec's wound-healing product to be marketed as OrCel; FDA advisory panel recommends approval

July 19, 2001

Autoimmune and inflammatory disease therapy alliance between Icos and Biogen

July 18, 2001

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...